Clicky

Teva Pharmaceutical Industries Ltd(TEVJF)

Description: Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides specialty medicines for use in central nervous system and respiratory indications. Its products in the central nervous system area comprise Copaxone for the treatment of relapsing forms of MS; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. The company has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.


Keywords: Pharmaceutical Medication Active Pharmaceutical Ingredients Asthma Pharmaceutical Industries Chronic Obstructive Pulmonary Disease Hormones Pulmonary Disease Ointments Hormone Dosage Form Pharmaceutical Ingredients Active Pharmaceutical Ingredient Osage Huntington Otsuka Pharmaceutical Dyskinesia Science And Technology In Israel Chorea Tardive Dyskinesia Teva Pharmaceutical Industries Treatment Of Asthma And Chronic Obstructive Pulmonary Disease Altus Huntington Disease Inhalants Glatiramer Acetate Kva Sterile Products Tardive Teva Deutetrabenazine Pharmac

Home Page: www.tevapharm.com

124 Dvora Haneviā€™a Street
Tel Aviv, 6944020
Israel
Phone: 972 3 914 8213


Officers

Name Title
Mr. Kare Schultz Pres, CEO & Director
Mr. Eliyahu Sharon Kalif Exec. VP & CFO
Mr. Eric Drape Exec. VP of Global Operations
Mr. Mark Sabag Exec. VP of International Markets Commercial
Dr. Sven Dethlefs Ph.D. Exec. VP of North America Commercial
Mr. Amir Weiss Sr. VP & Chief Accounting Officer
Mr. Kevin C. Mannix Sr. VP of Investor Relations
Mr. David M. Stark Exec. VP & Chief Legal Officer
Kathleen Veit Sr. VP, Global Compliance & Ethics Officer
Mr. Eli Shani Exec. VP of Global Marketing & Portfolio

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 3.4317
Trailing PE: 0
Price-to-Book MRQ: 1.1022
Price-to-Sales TTM: 0.6879
IPO Date:
Fiscal Year End: December
Full Time Employees: 34713
Back to stocks